Sarepta Therapeutics Inc (SRPT) support and resistance · rev $1.13B
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
This page maps Sarepta Therapeutics Inc (SRPT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
SRPT currently screens at market cap $2.34B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SRPT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SRPT quote page for the session range and the stock page for the full model.
Not investment advice.